CSIMarket


Anixa Biosciences Inc   (ANIX)
Other Ticker:  
 

Anixa Biosciences Inc

ANIX's Fundamental analysis








Anixa Biosciences Inc 's sales fell in III. Quarter 2023 from the same quarter a year ago.

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -8.1 %

Anixa Biosciences Inc net loss deacreased by in III. Quarter 2023 year on year, Anixa Biosciences Inc net loss increased by -8.18 % in III. Quarter 2023 year on year,

More on ANIX's Growth


Anixa Biosciences Inc
realized net loss in trailing twelve months.

Anixa Biosciences Inc realized cash outflow of $ -0.67per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
283.75
PE TTM    
Company's Price to Sales ratio is at 152.48.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.8.


More on ANIX's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 0.78

Anixa Biosciences Inc
realized net loss in trailing twelve months.

Anixa Biosciences Inc realized cash outflow of $ -0.67per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
283.75
PE TTM    
Company's Price to Sales ratio is at 152.48.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.8.

Anixa Biosciences Inc Price to Book Ratio is at 4.48 lower than Indusry Avg. of 1295.97. and higher than S&P 500 Avg. of -2057.92

More on ANIX's Valuation

  Market Capitalization (Millions $) 110
  Shares Outstanding (Millions) 31
  Employees 15
  Revenues (TTM) (Millions $) -
  Net Income (TTM) (Millions $) -11
  Cash Flow (TTM) (Millions $) -21
  Capital Exp. (TTM) (Millions $) -
  Total Debt (Millions $) -
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) -
  Tangible Book Value (Per Share $) 0.78

  Market Capitalization (Millions $) 110
  Shares Outstanding (Millions) 31
  Employees 15
  Revenues (TTM) (Millions $) -
  Net Income (TTM) (Millions $) -11
  Cash Flow (TTM) (Millions $) -21
  Capital Exp. (TTM) (Millions $) -





  Ratio
   Capital Ratio (MRQ) 14.22
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) 0.04
  Asset Turnover Ratio (TTM) -
  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com